Barrington Research Maintains Outperform on Stride, Lowers Price Target to $115
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $125 to $115.
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $125 to $115.